NCT07479446 2026-03-18
Oliceridine Versus Sufentanil for Postoperative Nausea in Cerebellopontine Angle Surgery
Xuanwu Hospital, Beijing
Phase NA Not yet recruiting
Clinical Trials
20 trialsNCT00598351 2026-03-11
Natural History Study of Patients With Neurofibromatosis Type 2
National Institutes of Health Clinical Center (CC)
Recruiting
NCT06517888 2026-03-04
Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma
Akouos, Inc.
Phase 1/2 Recruiting
NCT05786144 2026-01-30
Vestibular Schwannoma Organoids
Maastricht Radiation Oncology
Completed
NCT07364955 2026-01-23
Vestibular Rehabilitation Protocol in Unilateral Vestibular Schwannoma
Universitat Autonoma de Barcelona
Phase NA Recruiting
NCT06163664 2026-01-13
Role of ChatGPT in Vestibular Schwannoma Management
University of Southern California
Phase NA Withdrawn
NCT04374305 2026-01-12
INTUITT-NF2
Massachusetts General Hospital
Phase 2 Active not recruiting
NCT06322342 2025-12-26
Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent
Reveal Pharmaceuticals Inc.
Phase 2 Completed
NCT07305285 2025-12-26
Roy Adaptation Model Improves Mood and QOL After Giant Acoustic Neuroma
West China Hospital
Phase NA Completed
NCT03261726 2025-12-19
Maintaining Cochlear Patency After VIIIth Nerve Surgery
Henry Ford Health System
Phase NA Withdrawn
NCT03079999 2025-12-18
Study of Aspirin in Patients With Vestibular Schwannoma
Massachusetts Eye and Ear Infirmary
Phase 2 Active not recruiting
NCT07267910 2025-12-05
VESTI
Aalto University
Phase NA Not yet recruiting
NCT05622344 2025-11-10
SWAN
Johns Hopkins University
Phase NA Recruiting
NCT04057976 2025-09-12
Use of DTT to Define Facial Nerve Position in Vestibular Schwannomas
King's College Hospital NHS Trust
Phase NA Completed
NCT07130851 2025-08-19
Mapping of Vestibular Centers Activation Using fMRI in Patients With Vestibular Schwannoma
Charles University, Czech Republic
Phase NA Active not recruiting
NCT04743310 2025-06-13
Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System
Cedars-Sinai Medical Center
Phase 2 Completed
NCT03095248 2025-04-22
SEL-TH-1601
Children's Hospital Medical Center, Cincinnati
Phase 2 Terminated
NCT04196933 2025-04-16
Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma
Massachusetts Eye and Ear Infirmary
Phase NA Withdrawn
NCT01083966 2025-04-09
Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma
Northwell Health
Phase 1 Suspended
NCT02249572 2025-04-02
V-REX
Haukeland University Hospital
Phase NA Completed